What is MBOT's market cap?

$76.57M, based on the Nov 4 close of $1.14.

Does Microbot Medical pay a dividend?

No regular cash dividend has been paid in the last year.

How much of MBOT is sold short?

6.0M shares, 9.2% of float, as of Oct 15, 2026.

What sector is MBOT in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · MBOTHealthcareSurgical Instruments

Microbot Medical, Inc. Common Stock (MBOT)

$1.14+4.59%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$1.14▼ 43.56% in range

Nov 4, 2025Low $0.94 · High $2.85Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Microbot Medical closed at $1.14 on Nov 4, up 4.59%, 60.0% below its 52-week closing high. Volume of 782.5K shares was 0.98× its 20-day average (close to normal).

Split-adjusted performance: +6.5% over one month, -47.9% over six months, -46.2% over one year.

In the quarter ended Jun 30, 2026, revenue was $241K, with a net margin of -2334.9%.

Short interest was 6.0M shares at the Oct 15 settlement, down 9.8% from the prior report (9.2% of float, 6.6 days to cover).

Market cap$76.6M67.2M shares

Revenue · quarter$241.0K—

Diluted EPS$-0.08—

P/E · TTM—P/S 221.3×

Net margin-2,334.9%Gross -266.8%

Dividend yieldNone

52-week range0.94 – 2.85−60.0% from high

Volume782.5K0.98× 20-day avg

Volatility · 60d51.7%Annualised

Short % of float9.2%6.6 days to cover

Net cash$67.4MCash $67.4M

Next earnings—Not scheduled

Split-adjusted performance

1W +1.8%1M +6.5%3M −36.7%6M −47.9%YTD −43.0%1Y −46.2%3Y +0.9%5Y −84.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum24

Revenue growth—

Net margin4

Value (low P/E)—

Size37

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short6.0M−9.8% vs prior

Days to cover6.6Settled Oct 15

% of float9.2%

Short vol. 10d47.7%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
MBOTMicrobot Medical	$1.14	+4.59%	−47.9%	—	−2334.9%	—	$76.6M
SKINSkinHealth Systems	$11.05	+6.76%	−40.8%	−7.8%	−3.7%	—	$72.0M	Compare
LNSRLENSAR	$5.84	+4.85%	+8.4%	+18.4%	10.7%	4.6	$71.7M	Compare
LUCDLucid Diagnostics	$0.4451	+8.83%	−58.8%	+26.7%	−998.3%	—	$85.0M	Compare
APYXApyx Medical	$2.59	−0.38%	−11.3%	+22.1%	−23.4%	—	$109.1M	Compare
SRTSSensus Healthcare	$3.25	−1.07%	−20.5%	−68.7%	−382.1%	—	$53.5M	Compare
DXRDaxor	$8.91	+2.44%	−12.1%	+2.3%	−403.2%	—	$52.0M	Compare
SNWVSANUWAVE Health	$5.73	−3.37%	−64.0%	−3.1%	−7.0%	3.4	$49.3M	Compare
MDAISpectral AI	$1.53	+2.00%	−31.1%	−30.4%	−118.5%	—	$49.2M	Compare

News about Microbot Medical

All news →

Microbot Medical® Highlights Growth StrategyGlobeNewswire Inc. · Sep 25, 2026▲ Positive Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical EventGlobeNewswire Inc. · Mar 3, 2026▲ Positive

Quick answers

What does Microbot Medical do?: Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures.
What is MBOT's market cap?: $76.57M, based on the Nov 4 close of $1.14.
Does Microbot Medical pay a dividend?: No regular cash dividend has been paid in the last year.
How much of MBOT is sold short?: 6.0M shares, 9.2% of float, as of Oct 15, 2026.
What sector is MBOT in?: Healthcare, in the Surgical Instruments industry.

About Microbot Medical

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

HQ: Hingham, MA22 employeesListed Mar 25, 1992microbotmedical.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology